Maelstrom Research Staging | LIPiC_PositiveCohort

LIPiC_PositiveCohort_Followup2

Networks -

Variables -

Associated study LIPiC Contingency Table

Population

LIPiC - Positive Cohort

The population is composed of patients who recovered from COVID-19 infection in Hamilton, Ontario, Canada and who were tested as positive from the reverse transcriptase polymerase chain reaction (RT-PCR) test.

Selection Criteria

Newborns

Twins

Countries

Canada

Territory

Hamilton

Ethnic Origin

Health Status

Recovered from COVID-19 infection

Other Criteria

Tested as positive from the reverse transcriptase polymerase chain reaction (RT-PCR) test

Recruitment

Sources of recruitment

Specific population

Specific Population

Clinic patients

Supplementary Information

Study participants were recruited from patients who recovered from COVID-19 infection and were initially identified by treating physicians, Public Health and through hospital discharge databases that include hospitals in Hamilton, Ontario, Canada (Hamilton General Hospital, Juravinski Hospital, McMaster University Medical Centre, and St. Joseph’s Healthcare).

Number of Participants

Number of Participants: 200
Number of Participants with Biological Samples: 200

More info

Data Collection Event

LIPiC - Positive Cohort - Follow-up 2

COVID-19 antibody detection was performed using an in-house enzyme-linked immunosorbent assay (ELISA) on blood samples.

More info

Collected Dataset / LIPiC_PositiveCohort_Followup2

LIPiC_PositiveCohort_Followup2

Population

LIPiC - Positive Cohort

Data Collection Event

LIPiC - Positive Cohort - Follow-up 2

Files

Variables Classifications